MICS: gauge width impacts wound

Article

Gauges and knives used during microincision cataract surgery (MICS) should be of equal thickness, according to a study published in the July 2008 issue of the Journal of Cataract & Refractive Surgery.

Gauges and knives used during microincision cataract surgery (MICS) should be of equal thickness, according to a study published in the July 2008 issue of the Journal of Cataract & Refractive Surgery.

Dr Keisuke Kimura of Kosei Chuo Hospital, Tokyo, Japan and colleagues evaluated the impact of gauge thickness on wound measurement by measuring wound width before and after intraocular lens (IOL) implantation. Subjects were divided into groups with incisions of either 2.2 mm or 2.4 mm, and the team used either a 0.15 mm gauge (F-gauge), which was the same thickness as the knives used during surgery, or a 0.35 mm gauge (A-gauge) to measure the wounds.

The F-gauge measured the 2.2 mm incision wound as 2.20±0.03 mm before IOL implantation, compared with the A-gauge pre-insertion measurement of 2.16±0.05 mm; after insertion of the IOL, the F-gauge measured the wound width as 2.41±0.08 mm, compared with the A-gauge measurement of 2.35±0.09 mm. The F-gauge measured the 2.4 mm incision wound as 2.39±0.04 mm before IOL implantation, compared with the A-gauge pre-insertion measurement of 2.31±0.06 mm. The post-implantation wound width was measured as >2.5 mm for both groups.

The researchers noted that measurement errors increase when the gauge used is thicker than the knife; they concluded that a thicker gauge is less reliable for measuring wound width than is a gauge of equal thickness to the knife.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.